This workshop addresses young scientists working in basic pharmacological research and other colleagues involved in biomedical research who would like to know more about early phase clinical development. First-in-human trials will be the focus of this workshop. Non-clinical prerequisites, ethical and regulatory requirements, starting dose, dose escalation rules and stopping criteria, design aspects and clinical conduct, as well as pros and cons of integrated protocols will be addressed.
Discuss state-of-the art features of FIH trials with non-clinical and clinical experts. Breaks present a good opportunity to network with faculty and colleagues. The number of participants is limited to 50 persons. Participation fee is 40 Euro for delegates fully registered for the GPTS and 75 Euro for a day ticket for the AGAH Workshop only.